-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Lineage, Lowers Price Target to $36

Benzinga·10/20/2026 13:03:14
Listen to the news
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $45 to $36.